Prevalence of Metabolic Syndrome in Patients with Psoriasis

Table 1

Metabolic syndrome criteria in psoriasis patients and controls.

		Psoriasis (𝑛=115)	Control (𝑛=140)	^++ 𝑃
		𝑛 (%)	𝑛 (%)
Waist circumference (cm)	M≥94; F≥80	84 (73.0%)	117 (83.6%)	0,041*
	M<94; F<80	31 (27.0%)	23 (16.4%)
BMI (kg/m^2)		28.73±6.1	28.22±4.9	0.473
Triglyceride (mg/dL)	≥150	52 (45.2%)	55 (39.3%)	0.340
	<150	63 (54.8%)	85 (60.7%)
HDL (mg/dL)	F≤50; M≤40	50 (43.5%)	46 (32.9%)	0.082
	F>50; M>50	65 (56.5%)	94 (67.1%)
BP (mmHg)	≥130/85	47 (40.9%)	33 (23.6%)	0.003**
	<130/85	68 (59.1%)	107 (76.4%)
FBG (mg/dL)	≥100	56 (48.7%)	49 (35.0%)	0.027*
	<100	59 (51.3%)	91 (65.0%)
MS	(+)	61 (53.0%)	59 (39.0%)	0.004**
	(−)	54 (47.0%)	91 (65.0%)

⁺⁺Chi-square test, *𝑃<0.05, **𝑃<0.01.
BMI: Body Mass Index; MS: Metabolic syndrome; F: Female; M: Male; BP: Blood pressure; FBG: Fasting blood glucose.